Flynn James E
Deerfield Mgmt HIF L.P.
DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C)
Deerfield Healthcare Innovations Fund L.P.
Deerfield Mgmt L.P.
Deerfield Mgmt III L.P.
Deerfield Private Design Fund III L.P.
DEERFIELD PARTNERS L.P.
*Possible Member of 10% Group
10% Owner | 2024-02-01 17:29:56 | 2,613,012
0 | 2,613,012 | Form 13G |
Sanderling Venture Partners VI LP
Sanderling Venture Partners VI Co Investment Fund LP
Sanderling Ventures Management VI
Sanderling Ventures VII L.P.
Sanderling Ventures VII Annex Fund L.P.
Sanderling Ventures VII (Canada) L.P.
Sanderling Ventures Management VII
10% Owner | 2024-01-25 20:00:32 | 1,190,100
466,320 | 1,656,420 | Form 4 |
Valence Investments SPV IV LLC
Valence Investments SPV V LLC
Valence Investments SPV VI LLC
10% Owner | 2024-02-08 17:55:57 | 1,163,310
0 | 1,163,310 | Form 13D |
Keyoung Hansoo Michael
Director | 2020-09-29 16:40:20 | 0
1,133,596 | 1,133,596 | Form 4 |
Sanderling Venture Partners VI LP
Sanderling Venture Partners VI Co Investment Fund LP
Sanderling Ventures Management VI
Sanderling VI Beteiligungs GmbH & Co KG
Sanderling VI Limited Partnership
Sanderling Ventures VII L.P.
Sanderling Ventures VII Annex Fund L.P.
Sanderling Ventures Management VII
Sanderling Ventures VII (Canada) L.P.
10% Owner | 2023-10-10 16:15:11 | 725,284
54,047 | 779,331 | Form 4 |
ORBIMED ADVISORS LLC
OrbiMed Capital GP VI LLC
10% Owner | 2024-02-05 16:48:48 | 297,380
0 | 297,380 | Form 13D |
Leheny A. Rachel
CHIEF EXECUTIVE OFFICER
10% Owner | 2024-04-22 21:33:46 | 115,000
0 | 115,000 | Form 4 |
Hebbar Sudarshan
Chief Medical Officer | 2024-04-22 21:35:49 | 82,500
0 | 82,500 | Form 4 |
Roberts Eric W
CHIEF BUSINESS OFFICER
10% Owner | 2024-04-22 21:37:29 | 77,500
0 | 77,500 | Form 4 |
Dunn Michael J.
President and COO | 2024-04-22 21:40:48 | 62,500
0 | 62,500 | Form 4 |
Stauderman Kenneth A.
Chief Scientific Officer | 2024-04-22 21:39:37 | 62,500
0 | 62,500 | Form 4 |
BREUIL ROBERT S
Chief Financial Officer | 2023-03-27 19:56:09 | 35,326
0 | 35,326 | Form 4 |
Salain Daniel
CTOO | 2020-12-10 17:10:59 | 35,000
0 | 35,000 | Form 4 |
Zamiri Parisa
Chief Medical Officer | 2023-03-27 19:59:47 | 28,982
0 | 28,982 | Form 4 |
Geffken Daniel E.
Interim CFO | 2023-05-03 20:59:51 | 0
17,280 | 17,280 | Form 4 |
Cagle Gerald D.
Director | 2021-06-04 18:37:44 | 12,500
0 | 12,500 | Form 4 |
WILSON ROBERT N
Director | 2024-04-22 21:43:00 | 10000
0 | 10000 | Form 4 |
MIDDLETON FRED A
Director
10% Owner | 2024-04-22 21:46:08 | 10000
0 | 10000 | Form 4 |
Shaw Allan
Director | 2024-04-22 21:49:14 | 10000
0 | 10000 | Form 4 |
BJERKHOLT ERIC
Director | 2024-04-22 21:51:17 | 10000
0 | 10000 | Form 4 |
Guerard Frederic
Director | 2024-04-22 21:53:21 | 10000
0 | 10000 | Form 4 |
SHAFFER CHRISTY L
Director | 2023-03-27 19:59:08 | 1429
0 | 1429 | Form 4 |
Sauer Dirk
Director | 2023-03-27 19:58:21 | 1429
0 | 1429 | Form 4 |
EASTLAND JULIA MARIE
Director | 2023-03-27 19:57:01 | 1429
0 | 1429 | Form 4 |
ACKERMANN CHRISTINA
Director | 2023-03-27 19:54:44 | 1429
0 | 1429 | Form 4 |
Clarus Lifesciences III L.P.
Clarus Ventures III GP L.P.
Blackstone Clarus III L.L.C.
Blackstone Holdings II L.P.
Blackstone Holdings I/II GP L.L.C.
Blackstone Group Inc
Blackstone Group Management L.L.C.
SCHWARZMAN STEPHEN A
10% Owner | 2022-02-11 06:40:04 | 0
0 | 0 | Form 13G |